Skip to content

Budesonide and Rasa Sinex effects on allergic rhinitis

Comparison of Budesonide and Rasa Sinex nasal sprays on control of allergic rhinitis patients

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20110614006804N2
Enrollment
100
Registered
2021-01-15
Start date
2020-12-17
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Allergy. Condition 2: Allergy. Allergic rhinitis due to pollen Other seasonal allergic rhinitis

Interventions

Intervention 1: The first intervention group is consisted of people who receive Rasa sinex spray. This spray is made by Artiman Company, contain olive oil and black seeds extract. The patient should u

Sponsors

Bagheiat-allah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with allergic rhinitis who are confirmed by the clinical immunologist or Otolaryngologist

Exclusion criteria

Exclusion criteria: History of Asthma Acute bacterial sinusitis Recent topical or systemic Corticosteroid treatment Severe polyposis in rhino-endoscopy allergy to the black seeds and olive oil active nasal bleeding acute bronchitis pneumonia upper respiratory tract infection

Design outcomes

Primary

MeasureTime frame
Allergic symptoms severity score based on the European Standard Allergy Questionnaire (ECRHS SCREENING QUESTIONNAIRE). Timepoint: day 0 and day30. Method of measurement: we will use the Demographic information and symptom severity questionnaire based on the European Standard Allergy Questionnaire (ECRHS SCREENING QUESTIONNAIRE), a validated sample of which is used in Persian.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Javad Behzadnia

Bagheiat-allah University of Medical Sciences

behzadnia@bmsu.ac.ir+98 21 8126 2012

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026